(WTS) Watts Water Technologies - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US9427491025
Stock: Flow Control, Heating, Drainage, Water Quality
Total Rating 67
Risk 79
Buy Signal -0.59
| Risk 5d forecast | |
|---|---|
| Volatility | 25.7% |
| Relative Tail Risk | -10.3% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.30 |
| Alpha | 28.05 |
| Character TTM | |
|---|---|
| Beta | 0.772 |
| Beta Downside | 0.962 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.54% |
| CAGR/Max DD | 1.21 |
EPS (Earnings per Share)
Revenue
Description: WTS Watts Water Technologies March 04, 2026
Watts Water Technologies, Inc. (WTS) supplies water technology solutions across residential, commercial, and industrial sectors globally. Their product portfolio addresses fluid and energy management within buildings.
The companys offerings include flow control products like backflow preventers and pressure regulators, essential for maintaining water system integrity. They also provide HVAC and gas products, such as boilers and water heaters, which are core components of building infrastructure. Additionally, WTS offers drainage, water reuse, and water quality products, reflecting a comprehensive approach to water management.
WTS distributes its products through a diverse network, including wholesale distributors, OEMs, and retail chains. This multi-channel approach is common for industrial component suppliers. Investors should examine ValueRay for detailed financial metrics and competitive analysis.
Headlines to watch out for
- New construction and renovation spending impacts demand
- Raw material costs influence profit margins
- Regulatory changes affect product specifications
- Global economic conditions impact industrial demand
- Wholesale distribution channels drive sales volume
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income: 340.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA -1.23 > 1.0 |
| NWC/Revenue: 31.73% < 20% (prev 29.55%; Δ 2.18% < -1%) |
| CFO/TA 0.14 > 3% & CFO 402.0m > Net Income 340.8m |
| Net Debt (-207.8m) to EBITDA (526.6m): -0.39 < 3 |
| Current Ratio: 2.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (33.4m) vs 12m ago -0.30% < -2% |
| Gross Margin: 49.46% > 18% (prev 0.47%; Δ 4899 % > 0.5%) |
| Asset Turnover: 92.40% > 50% (prev 93.96%; Δ -1.56% > 0%) |
| Interest Coverage Ratio: 42.28 > 6 (EBITDA TTM 526.6m / Interest Expense TTM 10.8m) |
Altman Z'' 6.15
| A: 0.27 (Total Current Assets 1.29b - Total Current Liabilities 512.4m) / Total Assets 2.88b |
| B: 0.50 (Retained Earnings 1.43b / Total Assets 2.88b) |
| C: 0.17 (EBIT TTM 456.6m / Avg Total Assets 2.64b) |
| D: 1.53 (Book Value of Equity 1.31b / Total Liabilities 853.5m) |
| Altman-Z'' Score: 6.15 = AAA |
Beneish M -3.18
| DSRI: 1.07 (Receivables 294.0m/253.2m, Revenue 2.44b/2.25b) |
| GMI: 0.95 (GM 49.46% / 47.15%) |
| AQI: 0.64 (AQ_t 0.28 / AQ_t-1 0.44) |
| SGI: 1.08 (Revenue 2.44b / 2.25b) |
| TATA: -0.02 (NI 340.8m - CFO 402.0m) / TA 2.88b) |
| Beneish M-Score: -3.18 (Cap -4..+1) = AA |
What is the price of WTS shares?
As of March 11, 2026, the stock is trading at USD 306.57 with a total of 165,108 shares traded.
Over the past week, the price has changed by -4.46%, over one month by -2.53%, over three months by +11.68% and over the past year by +44.31%.
Over the past week, the price has changed by -4.46%, over one month by -2.53%, over three months by +11.68% and over the past year by +44.31%.
Is WTS a buy, sell or hold?
Watts Water Technologies has received a consensus analysts rating of 3.22.
Therefor, it is recommend to hold WTS.
- StrongBuy: 1
- Buy: 0
- Hold: 8
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the WTS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 338.6 | 10.4% |
| Analysts Target Price | 338.6 | 10.4% |
WTS Fundamental Data Overview March 07, 2026
P/E Trailing = 30.0747
P/E Forward = 27.1739
P/S = 4.1859
P/B = 5.2551
P/EG = 3.4001
Revenue TTM = 2.44b USD
EBIT TTM = 456.6m USD
EBITDA TTM = 526.6m USD
Long Term Debt = 197.7m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 197.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -207.8m USD (from netDebt column, last quarter)
Enterprise Value = 10.00b USD (10.21b + Debt 197.7m - CCE 405.5m)
Interest Coverage Ratio = 42.28 (Ebit TTM 456.6m / Interest Expense TTM 10.8m)
EV/FCF = 28.06x (Enterprise Value 10.00b / FCF TTM 356.3m)
FCF Yield = 3.56% (FCF TTM 356.3m / Enterprise Value 10.00b)
FCF Margin = 14.61% (FCF TTM 356.3m / Revenue TTM 2.44b)
Net Margin = 13.98% (Net Income TTM 340.8m / Revenue TTM 2.44b)
Gross Margin = 49.46% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 49.46% (prev 48.78%)
Tobins Q-Ratio = 3.47 (Enterprise Value 10.00b / Total Assets 2.88b)
Interest Expense / Debt = 1.37% (Interest Expense 2.70m / Debt 197.7m)
Taxrate = 26.06% (29.5m / 113.2m)
NOPAT = 337.6m (EBIT 456.6m * (1 - 26.06%))
Current Ratio = 2.51 (Total Current Assets 1.29b / Total Current Liabilities 512.4m)
Debt / Equity = 0.10 (Debt 197.7m / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = -0.39 (Net Debt -207.8m / EBITDA 526.6m)
Debt / FCF = -0.58 (Net Debt -207.8m / FCF TTM 356.3m)
Total Stockholder Equity = 1.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.91% (Net Income 340.8m / Total Assets 2.88b)
RoE = 17.82% (Net Income TTM 340.8m / Total Stockholder Equity 1.91b)
RoCE = 21.64% (EBIT 456.6m / Capital Employed (Equity 1.91b + L.T.Debt 197.7m))
RoIC = 16.00% (NOPAT 337.6m / Invested Capital 2.11b)
WACC = 8.61% (E(10.21b)/V(10.41b) * Re(8.76%) + D(197.7m)/V(10.41b) * Rd(1.37%) * (1-Tc(0.26)))
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.15%
[DCF] Terminal Value 78.58% ; FCFF base≈344.1m ; Y1≈404.7m ; Y5≈617.5m
[DCF] Fair Price = 349.1 (EV 9.37b - Net Debt -207.8m = Equity 9.57b / Shares 27.4m; r=8.61% [WACC]; 5y FCF grow 18.77% → 2.90% )
EPS Correlation: 76.49 | EPS CAGR: 13.49% | SUE: 2.46 | # QB: 5
Revenue Correlation: 85.83 | Revenue CAGR: 8.32% | SUE: 1.21 | # QB: 4
EPS next Quarter (2026-06-30): EPS=3.32 | Chg7d=+0.023 | Chg30d=+0.025 | Revisions Net=+4 | Analysts=11
EPS current Year (2026-12-31): EPS=11.77 | Chg7d=+0.489 | Chg30d=+0.499 | Revisions Net=+9 | Growth EPS=+11.3% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=12.76 | Chg7d=+0.749 | Chg30d=+0.763 | Revisions Net=+5 | Growth EPS=+8.4% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.67 (5 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 8.8% - Earnings Yield 3.3%)
[Growth] Growth Spread = +5.3% (Analyst 10.8% - Implied 5.4%)
P/E Forward = 27.1739
P/S = 4.1859
P/B = 5.2551
P/EG = 3.4001
Revenue TTM = 2.44b USD
EBIT TTM = 456.6m USD
EBITDA TTM = 526.6m USD
Long Term Debt = 197.7m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 197.7m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -207.8m USD (from netDebt column, last quarter)
Enterprise Value = 10.00b USD (10.21b + Debt 197.7m - CCE 405.5m)
Interest Coverage Ratio = 42.28 (Ebit TTM 456.6m / Interest Expense TTM 10.8m)
EV/FCF = 28.06x (Enterprise Value 10.00b / FCF TTM 356.3m)
FCF Yield = 3.56% (FCF TTM 356.3m / Enterprise Value 10.00b)
FCF Margin = 14.61% (FCF TTM 356.3m / Revenue TTM 2.44b)
Net Margin = 13.98% (Net Income TTM 340.8m / Revenue TTM 2.44b)
Gross Margin = 49.46% ((Revenue TTM 2.44b - Cost of Revenue TTM 1.23b) / Revenue TTM)
Gross Margin QoQ = 49.46% (prev 48.78%)
Tobins Q-Ratio = 3.47 (Enterprise Value 10.00b / Total Assets 2.88b)
Interest Expense / Debt = 1.37% (Interest Expense 2.70m / Debt 197.7m)
Taxrate = 26.06% (29.5m / 113.2m)
NOPAT = 337.6m (EBIT 456.6m * (1 - 26.06%))
Current Ratio = 2.51 (Total Current Assets 1.29b / Total Current Liabilities 512.4m)
Debt / Equity = 0.10 (Debt 197.7m / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = -0.39 (Net Debt -207.8m / EBITDA 526.6m)
Debt / FCF = -0.58 (Net Debt -207.8m / FCF TTM 356.3m)
Total Stockholder Equity = 1.91b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.91% (Net Income 340.8m / Total Assets 2.88b)
RoE = 17.82% (Net Income TTM 340.8m / Total Stockholder Equity 1.91b)
RoCE = 21.64% (EBIT 456.6m / Capital Employed (Equity 1.91b + L.T.Debt 197.7m))
RoIC = 16.00% (NOPAT 337.6m / Invested Capital 2.11b)
WACC = 8.61% (E(10.21b)/V(10.41b) * Re(8.76%) + D(197.7m)/V(10.41b) * Rd(1.37%) * (1-Tc(0.26)))
Discount Rate = 8.76% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -81.65 | Cagr: -0.15%
[DCF] Terminal Value 78.58% ; FCFF base≈344.1m ; Y1≈404.7m ; Y5≈617.5m
[DCF] Fair Price = 349.1 (EV 9.37b - Net Debt -207.8m = Equity 9.57b / Shares 27.4m; r=8.61% [WACC]; 5y FCF grow 18.77% → 2.90% )
EPS Correlation: 76.49 | EPS CAGR: 13.49% | SUE: 2.46 | # QB: 5
Revenue Correlation: 85.83 | Revenue CAGR: 8.32% | SUE: 1.21 | # QB: 4
EPS next Quarter (2026-06-30): EPS=3.32 | Chg7d=+0.023 | Chg30d=+0.025 | Revisions Net=+4 | Analysts=11
EPS current Year (2026-12-31): EPS=11.77 | Chg7d=+0.489 | Chg30d=+0.499 | Revisions Net=+9 | Growth EPS=+11.3% | Growth Revenue=+10.5%
EPS next Year (2027-12-31): EPS=12.76 | Chg7d=+0.749 | Chg30d=+0.763 | Revisions Net=+5 | Growth EPS=+8.4% | Growth Revenue=+5.3%
[Analyst] Revisions Ratio: +0.67 (5 Up / 1 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 5.4% (Discount Rate 8.8% - Earnings Yield 3.3%)
[Growth] Growth Spread = +5.3% (Analyst 10.8% - Implied 5.4%)